Richard Goitia serves as the Vice President of Finance at LGM Pharma, where he leverages over 15 years of diverse experience across pharmaceuticals, communications, and real estate to drive financial excellence and strategic growth. In his current role, Richard is instrumental in overseeing the financial...
Richard Goitia serves as the Vice President of Finance at LGM Pharma, where he leverages over 15 years of diverse experience across pharmaceuticals, communications, and real estate to drive financial excellence and strategic growth. In his current role, Richard is instrumental in overseeing the financial integration following LGM Pharma's acquisition of Nexgen Pharma, Inc.'s formulation development and drug product contract manufacturing business. This strategic move not only enhances LGM's capabilities in API sourcing and supply chain management but also positions the company as a leader in comprehensive drug product CDMO services.
Richard's expertise in accounting, internal controls, and financial reporting is pivotal as he navigates the complexities of this integration. He is particularly focused on optimizing working capital and ensuring compliance with the Sarbanes-Oxley Act, which is crucial for maintaining the integrity of financial operations in a rapidly evolving industry. His proficiency with financial systems such as Oracle, JDE Enterprise One, and Microsoft Dynamics GP enables him to streamline processes and enhance reporting accuracy.
Key projects under Richard's leadership include successful due diligence initiatives that have fortified LGM's market position and stabilized teams post-restructuring. His commitment to effective communication and team development has significantly lowered employee turnover, fostering a culture of resilience and adaptability. As LGM Pharma continues to expand its footprint in the pharmaceutical sector, Richard's strategic vision and financial acumen will be vital in steering the company toward sustainable growth and operational excellence.
